-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Beam Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2019 to Q2 2024.
- Beam Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$91.1M, a 10% decline year-over-year.
- Beam Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$143M, a 56.3% increase year-over-year.
- Beam Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$133M, a 54.2% increase from 2022.
- Beam Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$289M, a 22% increase from 2021.
- Beam Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$371M, a 90.5% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)